Delivery Order SPE2DB22D9316-SPE2DB25FYP12
Award Date
5/20/25
Potential Completion Date
6/11/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $1,256.77 and has an ultimate completion date of March 11, 2025. The contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a ceiling value of $10,054.24 and covers the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of April 8, 2025 and is not associated with any set-aside designation. DMS...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, at a ceiling value of $15,761.76. The delivery order has a firm fixed price pricing structure and runs through June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $5,027.12, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a completion date of May 21, 2025. DMS Pharmaceutical Group Inc. is an experienced federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA to provide a wide range of pharmaceutical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML. The contract has a ceiling value of $7,880.88 and an ultimate completion date of September 4, 2024. The delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows...
This is a firm-fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,256.77 contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 13, 2025 and was awarded on May 22, 2025. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc. is a key...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EYLEA 2 MG/0.05 ML SYRINGE 0.05ML, a pharmaceutical product, with a ceiling value of $58,670.40 and a performance period through May 30, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $79,250.40 and has an ultimate completion date of March 6, 2025. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. has a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2MG/0.05ML SY 1S, a pharmaceutical product, with a ceiling value of $1,222.30 and a period of performance through May 14, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, with a ceiling value of $7,880.88. The contract has a firm fixed-price pricing type and an ultimate completion date of June 3, 2024. This order is placed under a larger indefinite delivery contract (IDC) between DMS...